Pamela J Mink

Summary

Affiliation: Exponent Inc
Country: USA

Publications

  1. doi Pesticides and prostate cancer: a review of epidemiologic studies with specific agricultural exposure information
    Pamela J Mink
    Exponent Health Sciences Group, Exponent, Inc, Washington, DC 20036, USA
    Eur J Cancer Prev 17:97-110. 2008
  2. ncbi Evaluation of uncontrolled confounding in studies of environmental exposures and neurobehavioral testing in children
    Pamela J Mink
    Exponent Inc, Washington, DC 20036, USA
    Epidemiology 15:385-93. 2004
  3. ncbi Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women
    Pamela J Mink
    Exponent, Inc, Washington, DC 20036, USA
    Am J Clin Nutr 85:895-909. 2007
  4. ncbi The non-Hodgkin lymphomas: a review of the epidemiologic literature
    Dominik D Alexander
    Exponent Health Sciences Group, Exponent, Inc, Wood Dale, IL, USA
    Int J Cancer 120:1-39. 2007
  5. doi Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis
    Pamela J Mink
    Exponent, Health Sciences Practice, Washington, DC, USA
    Regul Toxicol Pharmacol 52:299-310. 2008
  6. doi A weight-of-evidence review of colorectal cancer in pesticide applicators: the agricultural health study and other epidemiologic studies
    Dominik D Alexander
    Exponent Inc, Health Sciences Practice, Chicago, IL 60661, USA
    Int Arch Occup Environ Health 85:715-45. 2012
  7. pmc Evaluation of epidemiology and animal data for risk assessment: chlorpyrifos developmental neurobehavioral outcomes
    Abby A Li
    Exponent Health Sciences Group, Menlo Park, California, USA
    J Toxicol Environ Health B Crit Rev 15:109-84. 2012
  8. ncbi Use of background inorganic arsenic exposures to provide perspective on risk assessment results
    Joyce S Tsuji
    Exponent, 15375 SE 30th Place, Suite 250, Bellevue, WA 98007, USA
    Regul Toxicol Pharmacol 48:59-68. 2007
  9. ncbi Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses
    Joyce S Tsuji
    Exponent, Inc, 15375 SE 30th Place, Suite 250, Bellevue, WA 98007, United States Electronic address
    Toxicology 317:17-30. 2014
  10. pmc Potential effects of chlorpyrifos on fetal growth outcomes: implications for risk assessment
    Pamela J Mink
    Exponent, Inc, Health Sciences Group, Menlo Park, California 94025 1133, USA
    J Toxicol Environ Health B Crit Rev 15:281-316. 2012

Detail Information

Publications35

  1. doi Pesticides and prostate cancer: a review of epidemiologic studies with specific agricultural exposure information
    Pamela J Mink
    Exponent Health Sciences Group, Exponent, Inc, Washington, DC 20036, USA
    Eur J Cancer Prev 17:97-110. 2008
    ..Existing evidence does not point to any pesticide as satisfying widely used guidelines for establishing causation: a strong, exposure-dependent and demonstrably unconfounded, unbiased association, documented in several studies...
  2. ncbi Evaluation of uncontrolled confounding in studies of environmental exposures and neurobehavioral testing in children
    Pamela J Mink
    Exponent Inc, Washington, DC 20036, USA
    Epidemiology 15:385-93. 2004
    ..We examined a priori the potential impact of confounding in a hypothetical study evaluating the association of a potentially neurotoxic environmental exposure with neurobehavioral function in children...
  3. ncbi Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women
    Pamela J Mink
    Exponent, Inc, Washington, DC 20036, USA
    Am J Clin Nutr 85:895-909. 2007
    ..Dietary flavonoids may have beneficial cardiovascular effects in human populations, but epidemiologic study results have not been conclusive...
  4. ncbi The non-Hodgkin lymphomas: a review of the epidemiologic literature
    Dominik D Alexander
    Exponent Health Sciences Group, Exponent, Inc, Wood Dale, IL, USA
    Int J Cancer 120:1-39. 2007
    ..The extent to which the etiology of NHL types may differ is important to resolve in ongoing and future studies...
  5. doi Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis
    Pamela J Mink
    Exponent, Health Sciences Practice, Washington, DC, USA
    Regul Toxicol Pharmacol 52:299-310. 2008
    ..More studies with detailed smoking history will help resolve whether smoking is an effect modifier...
  6. doi A weight-of-evidence review of colorectal cancer in pesticide applicators: the agricultural health study and other epidemiologic studies
    Dominik D Alexander
    Exponent Inc, Health Sciences Practice, Chicago, IL 60661, USA
    Int Arch Occup Environ Health 85:715-45. 2012
    ..To systematically evaluate epidemiologic studies on pesticides and colon cancer and rectal cancer in agricultural pesticide applicator populations using a transparent "weight-of-evidence" (WOE) methodological approach...
  7. pmc Evaluation of epidemiology and animal data for risk assessment: chlorpyrifos developmental neurobehavioral outcomes
    Abby A Li
    Exponent Health Sciences Group, Menlo Park, California, USA
    J Toxicol Environ Health B Crit Rev 15:109-84. 2012
    ..Neurodevelopmental behavioral, pharmacological, and morphologic effects occurred at doses that produced significant brain or red blood cell acetylcholinesterase inhibition in dams or offspring...
  8. ncbi Use of background inorganic arsenic exposures to provide perspective on risk assessment results
    Joyce S Tsuji
    Exponent, 15375 SE 30th Place, Suite 250, Bellevue, WA 98007, USA
    Regul Toxicol Pharmacol 48:59-68. 2007
    ..S. population, thereby providing perspective for risk communication and regulatory decision-making on arsenic in the environment and in consumer products...
  9. ncbi Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses
    Joyce S Tsuji
    Exponent, Inc, 15375 SE 30th Place, Suite 250, Bellevue, WA 98007, United States Electronic address
    Toxicology 317:17-30. 2014
    ..Additional studies that better characterize tobacco use and stratify analyses of arsenic and bladder cancer by smoking status are necessary to further examine risks of arsenic exposure for smokers...
  10. pmc Potential effects of chlorpyrifos on fetal growth outcomes: implications for risk assessment
    Pamela J Mink
    Exponent, Inc, Health Sciences Group, Menlo Park, California 94025 1133, USA
    J Toxicol Environ Health B Crit Rev 15:281-316. 2012
    ..Based on consideration of both the epidemiologic and animal data, maternal RBC AChE inhibition is a more sensitive endpoint for risk assessment than somatic developmental effects reviewed in this article...
  11. doi Occupational trichloroethylene exposure and kidney cancer: a meta-analysis
    Michael A Kelsh
    Health Science Practice, Exponent, Inc, Menlo Park, CA 94025, USA
    Epidemiology 21:95-102. 2010
    ..We conducted a meta-analysis of occupational studies of trichloroethylene-exposed workers to evaluate patterns of associations by study design, exposure assessment methods, and occupational groups...
  12. pmc Evaluation of exposure to arsenic in residential soil
    Joyce S Tsuji
    Exponent, Bellevue, Washington 98007, USA
    Environ Health Perspect 113:1735-40. 2005
    ..Similarly, questionnaire responses indicating soil exposure were not associated with increased urinary arsenic levels. Relatively low soil arsenic exposure likely precluded quantification of arsenic exposure above background...
  13. doi Factors that distinguish serious versus less severe strain and sprain injuries: an analysis of electric utility workers
    Michael A Kelsh
    Exponent, Inc, Health Sciences, Menlo Park, California 94025, USA
    Am J Ind Med 52:210-20. 2009
    ..This study examines factors associated with severe work-related sprain/strain injuries to the back, shoulder, and knees...
  14. pmc A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer
    Dominik D Alexander
    Health Sciences Practice, Exponent Inc, 185 Hansen Court, Suite 100, Wood Dale, IL 60191, USA
    Nutr J 9:50. 2010
    ..In conclusion, the results of this meta-analysis are not supportive of an independent positive association between red or processed meat intake and prostate cancer...
  15. ncbi A meta-analysis of occupational trichloroethylene exposure and liver cancer
    Dominik D Alexander
    Exponent Health Sciences, 185 Hansen Ct, Suite 100, Wood Dale, IL 60191, USA
    Int Arch Occup Environ Health 81:127-43. 2007
    ..To quantitatively evaluate this association and to examine sources of heterogeneity, we conducted a meta-analysis of occupational studies of TCE exposure and liver/biliary tract cancer...
  16. ncbi A meta-analysis of occupational trichloroethylene exposure and multiple myeloma or leukaemia
    Dominik D Alexander
    Exponent Health Sciences, 185 Hansen Court, Suite 100, Wood Dale, IL 60191, USA
    Occup Med (Lond) 56:485-93. 2006
    ..Trichloroethylene (TCE) has been widely used as an industrial solvent and degreasing agent...
  17. doi Summary and meta-analysis of prospective studies of animal fat intake and breast cancer
    Dominik D Alexander
    Exponent Health Sciences Practice, Wood Dale, IL, USA
    Nutr Res Rev 23:169-79. 2010
    ....
  18. doi A review and meta-analysis of red and processed meat consumption and breast cancer
    Dominik D Alexander
    Exponent Health Sciences Practice, Wood Dale, IL, USA
    Nutr Res Rev 23:349-65. 2010
    ....
  19. ncbi Multiple myeloma: a review of the epidemiologic literature
    Dominik D Alexander
    Exponent Health Sciences Group, Exponent, Inc, Wood Dale, IL, USA
    Int J Cancer 120:40-61. 2007
    ..More research is also needed on the genetic factors of multiple myeloma, given the strong familial clustering of the disease...
  20. ncbi A nested case-control study of prostate cancer and atrazine exposure
    Patrick A Hessel
    Exponent, Wood Dale, IL 60191, USA
    J Occup Environ Med 46:379-85. 2004
    ..54; 95% confidence interval, 1.69-82.20). There was no association between atrazine exposure and prostate cancer when those with > or =1 test were compared. There was no evidence for an association between atrazine and prostate cancer...
  21. ncbi Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease
    Abby A Li
    Health Sciences Practice, Exponent, Inc, San Francisco, California 94114, USA
    J Occup Environ Med 47:1059-87. 2005
    ..We conclude that the animal and epidemiologic data reviewed do not provide sufficient evidence to support a causal association between pesticide exposure and PD...
  22. doi Egg consumption and CHD and stroke mortality: a prospective study of US adults
    Carolyn G Scrafford
    Health Sciences Practice, Exponent Inc, 1150 Connecticut Avenue, NW suite 1100, Washington, DC 20036, USA
    Public Health Nutr 14:261-70. 2011
    ..To evaluate the relationship between egg consumption and CHD and stroke mortality using the Third National Health and Nutrition Examination Survey 1988-1994 (NHANES III) and follow-up survey...
  23. doi US mesothelioma patterns 1973-2002: indicators of change and insights into background rates
    Mary Jane Teta
    Exponent Inc, Health Sciences Practice, New York, New York, USA
    Eur J Cancer Prev 17:525-34. 2008
    ..The background rate for persons below age 50 is approximately one per million, independent of sex. Future data are needed to estimate this rate for older age groups...
  24. doi Epidemiologic studies of glyphosate and cancer: a review
    Pamela J Mink
    Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA 30322, USA
    Regul Toxicol Pharmacol 63:440-52. 2012
    ..Because generic exposure assessments likely lead to exposure misclassification, it is recommended that exposure algorithms be validated with biomonitoring data...
  25. pmc Dietary flavonoids and flavonoid-rich foods are not associated with risk of type 2 diabetes in postmenopausal women
    Jennifer A Nettleton
    Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA
    J Nutr 136:3039-45. 2006
    ....
  26. pmc Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study
    Gretchen J Cutler
    Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA
    Int J Cancer 123:664-71. 2008
    ..93, 95% CI: 0.86-1.00). This study provides further support for a beneficial effect of flavonoid intake on lung cancer risk, especially among current and past smokers...
  27. ncbi Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study
    Pamela J Mink
    Division of Cancer Prevention and Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
    Am J Epidemiol 156:349-52. 2002
    ..39, 95% confidence interval: 0.86, 2.23). Circulating insulin levels were not predictive of future breast cancer incidence, but there may be a weak association with type 2 diabetes, perhaps modulated via increased adiposity...
  28. ncbi Menopausal hormone replacement therapy and risk of ovarian cancer
    James V Lacey
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, MSC 7234, Rockville, MD 20852, USA
    JAMA 288:334-41. 2002
    ..The association between menopausal hormone replacement therapy and ovarian cancer is unclear...
  29. ncbi Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States)
    Mark P Purdue
    Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, MSC 7240, Executive Plaza South 8121, Rockville, MD 20892, USA
    Cancer Causes Control 16:965-73. 2005
    ....
  30. pmc HDL-cholesterol and incidence of breast cancer in the ARIC cohort study
    Anna M Kucharska-Newton
    Department of Epidemiology, University of North Carolina at Chapel Hill, NC, USA
    Ann Epidemiol 18:671-7. 2008
    ..S. communities...
  31. ncbi Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998
    Pamela J Mink
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA
    Cancer 95:2380-9. 2002
    ..Population-based incidence data for these neoplasms by histopathologic type and race are limited. Variation in rates may provide clues for future etiologic studies...
  32. ncbi Weight and length at birth and risk of early-onset prostate cancer (United States)
    Lori L Boland
    Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN 55454 1015, USA
    Cancer Causes Control 14:335-8. 2003
    ..A case-control study was conducted to examine the association of weight and length at birth with early-onset prostate cancer...
  33. ncbi Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis
    Mark E Sherman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
    Cancer 100:1045-52. 2004
    ..Comparison of the survival for women with LMP tumors staged as distant with women who have carcinoma may have important implications for diagnostic terminology and clinical management...
  34. ncbi Probabilities of death from breast cancer and other causes among female breast cancer patients
    Catherine Schairer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Natl Cancer Inst 96:1311-21. 2004
    ..We used data on breast cancer patients from the Surveillance, Epidemiology, and End Results (SEER) Program in a competing-risk analysis...
  35. ncbi Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women
    Celine M Vachon
    Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Epidemiology 13:66-71. 2002
    ..Nulliparity may be more strongly associated with an increased risk of ovarian cancer among women with a family history of breast or ovarian cancer, compared with women who do not have a family history of those cancers...